ABACAVIR SULFATE | A077844 | AUROBINDO PHARMA LTD
| Petition | Type | Filed | Status | Petitioner |
|---|---|---|---|---|
Paddock Laboratories, Inc., (Winston & Strawn LLP) - Citizen Petition FDA-2011-P-0486 · 4 docket documents Paddock Laboratories, Inc. filed a citizen petition on June 10, 2011, seeking paragraph IV patent certifications for numerous generic drug products including abacavir sulfate, various combination antiretroviral therapies, acyclovir sodium, albuterol sulfate formulations, alendronate sodium, and many | Other | 2011-07-19 | Granted | — |
Source: Regulations.gov. FDA citizen petitions matched by application number.
Highest NADAC/Unit
$0.6012
per ea
Lowest NADAC/Unit
$0.6012
per ea
Brand NDCs
0
Generic NDCs
4
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 65862007360ABACAVIR 300 MG TABLET | $0.6012 | EA | Generic | — | 2026-06-17 |
| 68084002121ABACAVIR 300 MG TABLET | $0.6012 | EA | Generic | — | 2026-06-17 |
| 00904687404ABACAVIR 300 MG TABLET | $0.6012 | EA | Generic | — | 2026-06-17 |
| 00904687406ABACAVIR 300 MG TABLET | $0.6012 | EA | Generic | — | 2026-06-17 |
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.